(Circulation. 2002;106:1433.)
© 2002 American Heart Association, Inc.
From the Department of Internal Medicine (A.S.W., S.M.P., G.A.Z.), The Huntsman Cancer Institute (S.M.P.), and The Program in Human Molecular Biology and Genetics (A.S.W., G.A.Z.), The University of Utah, Salt Lake City.
Correspondence to Guy Zimmerman, Program in Human Molecular Biology and Genetics, Eccles Institute of Human Genetics, 15 N 2030 East, Bldg. 533, Rm. 4220, University of Utah, Salt Lake City, UT 84112. E-mail guy.zimmerman@hmbg.utah.edu
Key Words: Editorials endothelium platelets leukocytes inflammation
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Adhesive and signaling interactions between endothelial cells and leukocytes are key mechanisms that mediate both targeting of the blood cells to specific sites and information transfer that results in change in their phenotypes and function.1 These events are beneficial in defense against microbes and wound surveillance and repair; however, in dysregulated inflammatory conditions such as atherosclerosis and its complications, including acute coronary syndromes and restenosis after interventional procedures, accumulation and activation of leukocytes can injure the host. The cellcell interactions and signaling mechanisms are complex in the game of inflammation, and there are a number of players. In addition to endothelial cells and leukocytes, platelets contribute to leukocyte accumulation and to changes in their behavior in both physiological and pathological conditions,2,3,4 emphasizing the intimate relationship between the thrombotic and inflammatory systems.
See p 1523
One mechanism involves direct adhesion of activated platelets to monocytes, neutrophils, or other leukocyte subclasses and binding of chemokines or lipid signaling molecules that are released from the platelets or displayed in a juxtacrine fashion on their surfaces (see below), to receptors on the leukocyte plasma membrane.3,5 In this issue of Circulation, Schober and co-workers6 report a different play in the inflammatory repertoire: platelets interacting with inflamed endothelial cells donate the CC chemokine regulated upon activation normal T cell expressed presumed secreted (RANTES) to the endothelial surface, where it acts as a cell-associated signal for adhesion of monocytes. A number of the observations were made with cultured endothelial monolayers, incubated under conditions of stasis or
Related Article:
Circulation 2002 106: 1523-1529.
This article has been cited by other articles:
![]() |
M. O'Donoghue, E. M. Antman, E. Braunwald, S. A. Murphy, P. G. Steg, A. Finkelstein, W. F. Penny, V. Fridrich, C. H. McCabe, M. S. Sabatine, et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Analysis. J. Am. Coll. Cardiol., August 18, 2009; 54(8): 678 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de la Motte, J. Nigro, A. Vasanji, H. Rho, S. Kessler, S. Bandyopadhyay, S. Danese, C. Fiocchi, and R. Stern Platelet-Derived Hyaluronidase 2 Cleaves Hyaluronan into Fragments that Trigger Monocyte-Mediated Production of Proinflammatory Cytokines Am. J. Pathol., June 1, 2009; 174(6): 2254 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Dokken The Pathophysiology of Cardiovascular Disease and Diabetes: Beyond Blood Pressure and Lipids Diabetes Spectr, July 1, 2008; 21(3): 160 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Danese, E. Dejana, and C. Fiocchi Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation J. Immunol., May 15, 2007; 178(10): 6017 - 6022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sabatine, C. P. Cannon, C. M. Gibson, J. L. Lopez-Sendon, G. Montalescot, P. Theroux, B. S. Lewis, S. A. Murphy, C. H. McCabe, E. Braunwald, et al. Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics: The PCI-CLARITY Study JAMA, September 14, 2005; 294(10): 1224 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Simeoni, B. R. Winkelmann, M. M. Hoffmann, S. Fleury, J. Ruiz, L. Kappenberger, W. Marz, and G. Vassalli Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis Eur. Heart J., August 2, 2004; 25(16): 1438 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kalvegren, M. Majeed, and T. Bengtsson Chlamydia pneumoniae Binds to Platelets and Triggers P-Selectin Expression and Aggregation: A Causal Role in Cardiovascular Disease? Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1677 - 1683. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |